Infliximab in a patient with ankylosing spondylitis and secondary IgA nephropathy requiring haemodialysis.
Marocchi
Elisa
E
Spadaro
Antonio
A
Giannakakis
Konstantinos
K
Priori
Roberta
R
Valesini
Guido
G
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005922:Glomerulonephritis, IGA / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D006801:Humans; D000069285:Infliximab; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000473:pathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D013167:Spondylitis, Ankylosing / Q000150:complications* / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab